Who is the CEO of GRAIL, Inc.?

The CEO of GRAIL, Inc. is Robert P. Ragusa.

What industry does GRAIL, Inc. belong to?

GRAIL, Inc. operates in the Medical - Diagnostics & Research industry within the Healthcare sector.

Where is GRAIL, Inc. headquartered?

GRAIL, Inc. is headquartered at 1525 O’Brien Drive, Menlo Park, CA, 94025, US.

What is the IPO date of GRAIL, Inc.?

GRAIL, Inc. went public on June 12, 2024.

How many employees does GRAIL, Inc. have?

GRAIL, Inc. has approximately 1,000 full-time employees.

GRAIL, Inc.

GRAL•NASDAQ

Healthcare

Medical - Diagnostics & Research

$40.29

$0.57(1.44%)

GRAIL, Inc. (GRAL) Company Profile & Overview

Explore GRAIL, Inc.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

GRAIL, Inc. (GRAL) Company Profile & Overview

GRAIL, Inc., a biotechnology company, focuses on developing technologies for early cancer detection. The company develops Galleri, a screening test for asymptomatic individuals over 50 years of age; and DAC, a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients for whom there is a clinical suspicion of cancer. It is also developing minimal residual disease and other post-diagnostic tests. The company was incorporated in 2015 and is based in Menlo Park, California. GRAIL, Inc. operates as a former subsidiary of Illumina, Inc.

SectorHealthcare

IndustryMedical - Diagnostics & Research

CEORobert P. Ragusa

Contact Information

https://grail.com

833-694-2553

1525 O’Brien Drive, Menlo Park, CA, 94025

Company Facts

1,000 Employees

IPO DateJun 12, 2024

CountryUS

Actively Trading

Frequently Asked Questions

;